Li Hui Chang
Director of Finance/CFO at FORMOSA OPTICAL TECHNOLOGY CO.,LTD.
Li Hui Chang active positions
| Companies | Position | Start | End |
|---|---|---|---|
| FORMOSA OPTICAL TECHNOLOGY CO.,LTD. | Comptroller/Controller/Auditor | 05/11/1995 | - |
| Director of Finance/CFO | 05/11/1995 | - | |
| Investor Relations Contact | - | - | |
| Public Communications Contact | - | - | |
| POLYLITE TAIWAN CO., LTD. | Director/Board Member | 31/05/2006 | - |
Essilor Amera Pte Ltd.
 Essilor Amera Pte Ltd. Medical SpecialtiesHealth Technology Part of EssilorLuxottica SA, Essilor Amera Pte Ltd. is a Singaporean company that specializes in vision-related products and services. The company is based in Singapore, Singapore. The company's flagship product, Myopilux, is an all-in-one treatment for children's myopia that has been proven to reduce myopia evolution by up to 62%%. The company also offers Transitions lenses that adapt to any light condition, as well as a range of prescription lenses for glasses. | Director/Board Member | - | - |
Career history of Li Hui Chang
Training of Li Hui Chang
| Fu Jen Catholic University | Undergraduate Degree |
Statistics
International
| Taiwan | 4 |
| Singapore | 2 |
Operational
| Director/Board Member | 2 |
| Comptroller/Controller/Auditor | 1 |
| Director of Finance/CFO | 1 |
Sectoral
| Health Technology | 3 |
| Process Industries | 2 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| FORMOSA OPTICAL TECHNOLOGY CO.,LTD. | Health Technology |
| POLYLITE TAIWAN CO., LTD. | Process Industries |
| Private companies | 1 |
|---|---|
Essilor Amera Pte Ltd.
Essilor Amera Pte Ltd. Medical SpecialtiesHealth Technology Part of EssilorLuxottica SA, Essilor Amera Pte Ltd. is a Singaporean company that specializes in vision-related products and services. The company is based in Singapore, Singapore. The company's flagship product, Myopilux, is an all-in-one treatment for children's myopia that has been proven to reduce myopia evolution by up to 62%%. The company also offers Transitions lenses that adapt to any light condition, as well as a range of prescription lenses for glasses. | Health Technology |
- Stock Market
- Insiders
- Li Hui Chang
- Experience
